Founder of The Longevity Fund and age1, two VC firms backing aging-focused biotech, and CEO of Cradle, a startup pursuing reversible human cryopreservation.
Founder of The Longevity Fund and age1, two VC firms backing aging-focused biotech, and CEO of Cradle, a startup pursuing reversible human cryopreservation.
Price
$39.42
▼-55.90%today
Last raised$55M·Round·Jun 2023
Newstaller pin = bigger storyTap a pin to see headlines + price impact
Built first VC firm focused exclusively on aging and life extension
About
Laura Deming is one of the original architects of the longevity venture stack.
Accomplishments
Founded The Longevity Fund at age 17 after Thiel Fellowship
Raised $22M for Longevity Fund II in 2017 backing aging-focused biotech
Co-launched age1, a $55M fund for early-stage longevity startups, in 2023
Co-founded and CEO of Cradle, pursuing reversible whole-body cryopreservation
Joined Cynthia Kenyon's UCSF aging lab at age 12; admitted to MIT at 14
Pricing breakdown
Accomplishments22 · 35%
Funding · $0.00 raised
Mainstream popularity50 · 25%
Social popularity45 · 25%
X · 100.5K followers · 0.4 tweets/day · verified
Net worth40 · 15%
Composite
38/100
Intrinsic
$39.42
Market
+0.00%
Intrinsic price is set by the four-factor fundamentals score (35/25/25/15). Market price floats around it via a constant-product AMM — every trade moves the curve.
